surpass tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial Read now: The SURPASS-EARLY trial
Pay in 4 interest-free payments of $5.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31


01443-4/asset/1245bc8d-99c6-4ac1-b69b-8c0220ceb8fd/main.assets/gr1.jpg)





















